Insight

David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

Photo taken from David J. Benjamin/X

Sep 5, 2024, 07:11

David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

David J. Benjamin, Hematology-Oncology specialist, shared a post on X:

“Congratulations Andrea Apolo and colleagues on the latest publication in Patient Journal. With a growing armamentarium of therapies, it is critical for oncologists to understand what is important to individuals being treated for locally advanced/metastatic urothelial carcinoma.”

Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding

Authors: Andrea B. Apolo, Christine Michaels-Igbokwe, Nicholas I. Simon, David J. Benjamin, Mallory Farrar, Zsolt Hepp, Lisa Mucha, Sebastian Heidenreich, Katelyn Cutts, Nicolas Krucien, Natasha Ramachandran & John L. Gore

Source: David J. Benjamin/X

Andrea Apolo Andrea B Apolo cancer cancer awareness Christine Michaels-Igbokwe David J. Benjamin John L. Gore Katelyn Cutts Lisa Mucha Mallory Farrar Natasha Ramachandran Nicholas I Simon Nicolas Krucien OncoDaily Oncology Patient Journal Sebastian Heidenreich Zsolt Hepp

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage